Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium

Infection and Immunity

Volumn 65, Issue 6, 1997, Pages 2100-2106

  Eriks, Inge S ^a   Emerson, Carlene L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERIAL VIRULENCE; CELL SURVIVAL; DOWN REGULATION; DRUG RECEPTOR BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MOUSE; MYCOBACTERIOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

ANIMALS; DINOPROSTONE; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MYCOBACTERIUM AVIUM; NITRIC OXIDE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE;

EID: 0030926081     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 2. J. Immunol. 153:1674-1686.
2. Appelherg, R., A. G. Castro, J. Pedrosa, R. A. Silva, I. M. Orme, and P. Minóprio.1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independenl and -dependent phases of Mycobacterium avium infection. Infect. Immun. 62:3962-3971.
3. Appelbers, R., and I. M. Orme. 19931. Eflector mechanisms involved in cytokine-rnediated hacteriostasis of Mycobacterium avium in murine macrophages. Immunology 80:352-359.
4. Arai, T., K. Hiromatsu, H. Nishimura, V. Kimura, N. Kohavashi, H. Ishida, V. Nimura, and V. Yoshikai. 1995. Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection, Biochem. Biophys. Res. Commun. 213:600-607.
5. Bermudez, L. E. M., P. Stevens, P. Kolonoski, M. Wu, and L. S. Young. 1989. Treatment of experimental disseminated Mycobacterium avium complex in mice with recombinant IL-2 and tumor necrosis factor. J. Immunol, 143: 2996-3000.
6. Bermudez, L. E., M. Wu, M. Petrofsky, and L. S. Young. 1992. Interleukin-6 antagonizes tumor necrosis factor-mediated mycobacteriostatic and mycobactericidal activities in macrophages. Infect. Immun. 60:4245-4252.
7. Bermudez, L. E. M., and L. S. Young. 1988. Tumor necrosis factor, alone or in combination with IL-2. hut not IFN-γ. is associated with macrophage killing of Mycobacterium avium complex. J. Immunol. 140:3006-3013.
8. S. Branch, D. R., A. Shah, and L. J. Guilbert. 1991. A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors, J. Immunol. Methods 143:251-261.
9. Braun, R. K., C. D. Buergelt, R. C. Litteil, S. B. Linda, and J. R. Simpson. 1990. Use of an enzyme-linked immunosorbent assay to estimate the prevalence of paratuberculosis in cattle of Florida, J. Am. Vet. Med. Assoc. 196:1251-1254.
10. 3 FEMS Microbiol. Immunol. 89:281-286.
11. Chumpsi, J., L. S. Young, and L. E. Bermudez. 1995. Production of TNF-α, IL-6 and TGF-β, and expression of receptors for TNF-α and IL-6, during murine Mycobacterium avium infection. Immunology 84:549-554.
12. - activity. Microb. Pathog. 13:447-463.
13. + T-cell cytotoxicity. Microb. Pathog. 14:355-367.
14. Denis, M. 1991. Modulation of Mycobacterium avium growth in vivo by cytokines: involvement of tumour necrosis factor in resistance to atypical mycobacteria. Clin. Exp. Immunol. 83:466-471.
15. Denis, M. 1991, Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium. killing effector mechanism depends on the generation of reactive nitrogen intermediates. J. Leukocyte Biol. 49:380-387.
16. Denis, M., and E. O. Gregg. 1991. Modulation of Mycobucterium avium growth in murine macrophages: reversal of unresponsiveness to Interferongamma by indomethacin or interleukin-4. J. Leukocyte Biol. 49:65-72.
17. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412.
18. Dumarty, C. H., V. Labrnusse, N. Rastogi, B. H. Vargaftig, and M. Bachelet. 1094. Selective Mycobacterium aviumn-induced production of nitric oxide by human monocyte-derivcd macrophages. J. Leukocyte Biol. 56:36-40.
19. Endogen Inc. Personal communication.
20. Flesch, I. E. A., and S. H. E. Kaufmann. 1991. Mechanisms involved in mycobacterinl growth inhibition hy gamma interfcron-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218.
21. Friedland, J. S., R. J. Shattock, J. D. Johnson, G. Remick, R. E. Holliman, and G. E. Griffin, 1993. Differential cytokine gene expression and secretion after phagocytosis by a human monocytic cell line of Toxoplasma gondii compared with Mycobacterium tuberclosis. Clin. Exp. Immunol. 91:282-286.
22. Furney, S. K., P. S. Skinner, A. D. Roberts, R. Appelberg, and I. M. Orme, 1992. Capacity of Mycobacterium aviumm isolates to grow well or poorly in murine macrophages resides in their ability to induce secretion of tumor necrosis factor. Infect. Immun. 60:4410-4413.
23. Genzyme Corp. Personal communication.
24. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94.
25. Holtmann, H., T. Hahn, and D. Wallach. 1988. Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. Immunobiology 177:7-22.
26. Linderholm, M., C. Ahlm, B. Settergren, A. Waage, and A. Tarnvik, 1996. Elevated plasma levels of tumor necrosis factor (TNF)-α. soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173:38-43.
27. Merkal, R. S., D. L. Whipple, J. M. Sacks, and G. R. Snyder. 1987. Prevalence of Mycobacterium paratuberculiosis in ileocecal lymph nodes of cattle culled in the United States. J. Am. Vet. Mod. Assoc. 190:676-680.
28. Orme, I. M., S. K. Furney, P. S. Skinner, A. D. Roberts, P. J. Brennan, D. G. Russell, H. Shiratsuchi, J. J. Ellner, and W. Y. Weiser. 1993. Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inbibitory factor. Infect. Immun, 61:338-342.
29. Pontzer, C. H., and S. W. Russell. 1984. Culture of macrophages from bovine bone marrow. Vet. Immunol. Immunopathol. 21:351-362.
30. Thoen, C. O. 1992. Tuberculosis, p. 617-626. In A. D. Leman. B. E. Straw. W. L. Mengeling. S. D'Allaire, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press. Amos.
31. Thoen, C. O., and A. G. Karlson. 1991. Tuberculosis, p. 172-185. In B. W. Calnck (ed.), Diseases of poultry. Iowa State University Press. Ames.
32. Tsang, A. Y., J. C. Denner, P. J. Brennan, and J. K. McClatchy. 1992. Clinical and epidemiological importance of typing Mycobacterium aivium complex isolates. J. Clin. Microbiol. 30:479-484.
33. Warren, M. K., and S. N. Vogel. 1985. Bone marrow-derived macrophages: development and regulation of differentiation markers by colony-stimulating factor and interferons. J. Immunol. 134:982-989.
34. Wu, J., F. Q. Cunha, F. Y. Liow, and W. Y. Weiser. 1993. IL-10 inhibits the synthesis of migration inhibitory factor and migration inhibitory factor-mediated macrophage activation. J. Immunol. 151:4325-4332.
35. Young, L. S. 1988. Mycobacterium avium complex infection. J. Infect. Dis. 157:863-867.